1A6 (anti-FGF19) is a humanized monoclonal antibody that specifically targets FGF19. 1A6 (anti-FGF19) has antitumoe activities and can used in the treatment of hepatocellular carcinoma (HCC).
Specification: Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB209904-SCI_0aa1572ecc874af09e42bf25fad91754.pdf
- UPC:
- 41181909
- Condition:
- New
- Availability:
- 4-8 weeks
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab209904-1mg
- Product Size:
- 1mg